Amarantus BioScience Holdings, Inc. (AMBS)

Market Cap	630.00
Revenue (ttm)	n/a
Net Income (ttm)	-7.94M
Shares Out	630.41M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,020
Average Volume	753
Open	0.0001
Previous Close	0.0003
Day's Range	0.0001 - 0.0003
52-Week Range	n/a
Beta	-33.05
RSI	45.02
Earnings Date	n/a

About AMBS

Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company’s diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer’s disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a sma...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 12
• Stock Exchange: OTCMKTS
• Ticker Symbol: AMBS